From Drug Benefit News - As the prices of many generic drugs continue to experience increases due to shortages, reduced competition and other potential factors, the federal government is putting the pressure on the generic pharmaceutical industry. Sen. Bernie Sanders (I-Vt.), chairman of the Senate Subcommittee on Primary Health and Aging, on Nov. 20 convened a Senate hearing to investigate the “skyrocketing” prices of generic drugs at which three generic drugmakers were no-shows. Read more
From Specialty Pharmacy News - Although limited-distribution arrangements are not new to the specialty drug arena, one manufacturer’s changes to how its specialty pharmaceuticals are distributed are prompting outcries from providers and hospitals. In the latest development, a group of executives from academic medical centers are urging Congress to review the switch by manufacturer Genentech, Inc. Read more
From Drug Benefit News - Contrave (naltrexone HCl and bupropion HCl) last month joined the growing category of anti-obesity medications available by prescription in the U.S. (DBN 10/24/14, p. 8). Read more
Check out all of the benefits, sample issues & more!